Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units

Time to Retire the Concept of Transient Ischemic Attack

(2022) J. Donald Easton et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mobile Stroke Units: Evidence, Gaps, and Next Steps

(2022) Babak B. Navi et al.   STROKE

Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association

(2021) Salim S. Virani et al.   CIRCULATION

Prospective, Multicenter, Controlled Trial of Mobile Stroke Units

(2021) James C. Grotta et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reversible diffusion-weighted imaging lesions in acute ischemic stroke

(2020) Nandakumar Nagaraja et al.   NEUROLOGY

Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3

(2019) Vaishnavi Rao et al.   STROKE

Ischemic Diffusion Lesion Reversal After Endovascular Treatment

(2019) Joonsang Yoo et al.   STROKE

Ischaemic stroke

(2019) Bruce C. V. Campbell et al.   Nature Reviews Disease Primers

Time From Imaging to Endovascular Reperfusion Predicts Outcome in Acute Stroke

(2018) Jenny P. Tsai et al.   STROKE

Fast Versus Slow Progressors of Infarct Growth in Large Vessel Occlusion Stroke

(2017) Marcelo Rocha et al.   STROKE

Treatment With Tissue Plasminogen Activator in the Golden Hour and the Shape of the 4.5-Hour Time-Benefit Curve in the National United States Get With The Guidelines-Stroke PopulationClinical Perspective

(2016) Joon-Tae Kim et al.   CIRCULATION

Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

(2014) Gregg C. Fonarow et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

(2014) Jonathan Emberson et al.   LANCET

Imaging Negative Stroke: Diagnoses and Outcomes in Intravenous Tissue Plasminogen Activator–Treated Patients

(2013) Ilana Spokoyny et al.   Journal of Stroke & Cerebrovascular Diseases

Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator is Rare and Unlikely to Indicate Averted Infarction

(2013) Jason W. Freeman et al.   STROKE

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia

(2010) O. Y. Chernyshev et al.   NEUROLOGY

Transient Ischemic Attack after Tissue Plasminogen Activator: Aborted Stroke or Unnecessary Stroke Therapy?

(2009) Ken Uchino et al.   CEREBROVASCULAR DISEASES